StockData
Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc. (FTH) stock

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$10.65−2.70 (-20.22%)

Close on Nov 12, 2026Market cap $275.20MP/E –Yield –

Faeth Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Faeth Therapeutics's total assets was $189.31M at Jun 30, 2026. For fiscal 2025 it was $22.90M, down 49.5% from the year before. The highest annual figure on record is $153.23M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$22.90M-49.5%
FY2024Dec 31, 2024$45.36M-39.0%
FY2023Dec 31, 2023$74.37M-37.2%
FY2022Dec 31, 2022$118.38M-22.7%
FY2021Dec 31, 2021$153.23M+615.1%
FY2020Dec 31, 2020$21.43M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$189.31M+495.6%
Q1 FY2026Mar 31, 2026$205.38M+436.6%
Q4 FY2025Dec 31, 2025$22.90M-49.5%
Q3 FY2025Sep 30, 2025$27.59M-48.2%
Q2 FY2025Jun 30, 2025$31.78M-46.9%
Q1 FY2025Mar 31, 2025$38.27M-42.6%
Q4 FY2024Dec 31, 2024$45.36M-39.0%
Q3 FY2024Sep 30, 2024$53.25M-34.8%
Q2 FY2024Jun 30, 2024$59.80M-33.2%
Q1 FY2024Mar 31, 2024$66.70M-38.2%
Q4 FY2023Dec 31, 2023$74.37M-37.2%
Q3 FY2023Sep 30, 2023$81.66M-36.6%
Q2 FY2023Jun 30, 2023$89.58M-35.1%
Q1 FY2023Mar 31, 2023$107.93M-28.1%
Q4 FY2022Dec 31, 2022$118.38M-22.7%
Q3 FY2022Sep 30, 2022$128.80M-20.1%
Q2 FY2022Jun 30, 2022$138.04M-17.7%
Q1 FY2022Mar 31, 2022$150.04M-14.0%
Q4 FY2021Dec 31, 2021$153.23M+615.1%
Q3 FY2021Sep 30, 2021$161.25M–
Q2 FY2021Jun 30, 2021$167.72M–
Q1 FY2021Mar 31, 2021$174.48M–
Q4 FY2020Dec 31, 2020$21.43M–

More Faeth Therapeutics figures

See a number that looks wrong?